This suggests that CS/Res/SeNPs could offer a novel strategy for improving T2DM management by normalizing serum biochemical parameters, treating hyperglycemia, improving insulin sensitivity, and attenuating oxidative stress, inflammation, and apoptosis in liver tissues. This evidence concerns the gene INS and Hyperglycemia.